PMID: 11921147Mar 29, 2002Paper

Reducing the burden of caring for Alzheimer's disease through the amelioration of "delusions of theft" by drug therapy

International Journal of Geriatric Psychiatry
Kazue ShigenobuHirotaka Tanabe

Abstract

Delusions of theft (delusions involving the theft of possessions) are one of the most frequent neuropsychiatric manifestations of Alzheimer's disease (AD). The current study investigated the presence and extent of such delusions before and after drug treatment in a group of AD patients, and the consequent effects on the burden of care on caregivers. The study was an open-label cohort design. The delusions studied consisted only of those involving theft of possessions. Sixteen AD patients served as subjects in order to assess the efficacy of Risperidone administration, in the reduction or elimination of these delusions. The caregiver burden was evaluated using the Zarit Caregiver Burden Interview (ZBI) before the administration of Risperidone and 12 weeks after administration, for cases where delusions of theft were eliminated or reduced. The burden of care on caregivers was significantly reduced (p < 0.001) through the elimination or reduction of delusions of theft. Delusions of theft are considered to be a major factor in increasing the burden of care, and the treatment of these, through appropriate drug therapy, is therefore of great importance in the continuation of satisfactory care in the home.

References

Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Jul 1, 1990·The British Journal of Psychiatry : the Journal of Mental Science·A BurnsR Levy
May 1, 1989·The American Journal of Psychiatry·R E Wragg, D V Jeste
Jun 1, 1986·The Gerontologist·S H ZaritJ M Zarit
Oct 1, 1985·Journal of the American Geriatrics Society·J KahanK Brummel-Smith
Jun 1, 1982·The British Journal of Psychiatry : the Journal of Mental Science·C P HughesR L Martin
Dec 1, 1980·The Gerontologist·S H ZaritJ Bach-Peterson
Dec 1, 1994·The Gerontologist·E D RankinM D Franzen
Apr 1, 1993·The American Journal of Psychiatry·A C CoyneL J Berbig
Jan 1, 1996·Neurology·M S MegaJ Gornbein
Dec 31, 1997·Psychiatry and Clinical Neurosciences·Y AraiS Hisamichi
Jan 7, 1999·Alzheimer Disease and Associated Disorders·N NagaratnamL Palazzi
Apr 18, 2000·International Journal of Geriatric Psychiatry·A Burns, P Rabins
Apr 18, 2000·International Journal of Geriatric Psychiatry·P P De Deyn, I R Katz
Nov 23, 2000·Neurology·L TeriUNKNOWN Alzheimer's Disease Cooperative Study

❮ Previous
Next ❯

Citations

Oct 5, 2007·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·Eunjoo LeeKenichi Meguro
Feb 9, 2006·Behavioral Medicine·Roberta RielloGiovanni B Frisoni
Jul 14, 2004·Alzheimer Disease and Associated Disorders·Frank M TortiKevin A Schulman
Jun 10, 2009·Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology·Eunjoo LeeHiroshi Fukuda
May 8, 2010·Psychiatry and Clinical Neurosciences·Takemi KimuraJunichi Takamatsu
Nov 26, 2010·Psychiatry and Clinical Neurosciences·Masatoshi TakedaRamón Cacabelos
Aug 12, 2006·Dementia and Geriatric Cognitive Disorders·Corinne FischerSean B Rourke
Feb 15, 2007·Dementia and Geriatric Cognitive Disorders·Naomi MatsumotoHirotaka Tanabe
Dec 15, 2007·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Tetsuaki Arai
Nov 18, 2006·Drugs & Aging·Alistair Burns, Peter P De Deyn
Jun 13, 2009·Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics·Manabu Ikeda, Yusuke Yatabe
Sep 18, 2010·Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics·Mamoru Hashimoto
Mar 24, 2006·The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists·Patricia W Slattum, Mary Ann Johnson
Apr 21, 2017·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·S E Van Pilsum RasmussenD L Segev
Aug 16, 2005·Journal of Geriatric Psychiatry and Neurology·Seishi TeradaShigetoshi Kuroda
Apr 28, 2005·Expert Review of Neurotherapeutics·Manabu Ikeda, Hirotaka Tanabe
Feb 15, 2014·American Journal of Alzheimer's Disease and Other Dementias·Jiska Cohen-MansfieldRinat Cohen
Mar 9, 2004·American Journal of Alzheimer's Disease and Other Dementias·Corinne FischerMireille Norris
May 26, 2004·Journal of Geriatric Psychiatry and Neurology·Kenichi MeguroMasatoshi Itoh
Mar 8, 2007·Journal of Geriatric Psychiatry and Neurology·Eunjoo LeeEtsuro Mori
May 8, 2002·International Journal of Geriatric Psychiatry
Jun 6, 2003·International Journal of Geriatric Psychiatry·Manabu IkedaHirotaka Tanabe
Sep 11, 2018·International Journal of Geriatric Psychiatry·Ahmet Turan IsikNicola Veronese
Mar 9, 2007·International Journal of Geriatric Psychiatry·Yasutaka ToyotaHirotaka Tanabe
Jan 11, 2019·Journal of Clinical Psychopharmacology·Shinichiro OchiShu-Ichi Ueno
Jul 3, 2002·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Margaret M Swanberg, Jeffrey L Cummings
Jul 25, 2013·Geriatrics & Gerontology International·Gabriele CiprianiClaudio Lucetti
Jun 30, 2018·The Psychiatric Quarterly·Mary V Seeman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved